TrialTrials2026

Randomized, double-blind, placebo-controlled study of oral duloxetine in prevention of acute pain syndrome in breast cancer patients receiving paclitaxel (DOPA study).

Jahnavi Banotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.